Literature DB >> 12753741

CD4(+)CD3(-) accessory cells costimulate primed CD4 T cells through OX40 and CD30 at sites where T cells collaborate with B cells.

Mi-Yeon Kim1, Fabrina M C Gaspal, Helen E Wiggett, Fiona M McConnell, Adam Gulbranson-Judge, Chandra Raykundalia, Lucy S K Walker, Margaret D Goodall, Peter J L Lane.   

Abstract

In this report we identify an accessory cell that interacts with primed and memory T cells at sites where they collaborate with B cells. These cells are distinguished from conventional dendritic cells by their lack of response to Flt3 ligand and their inability to process antigen. Unlike dendritic cells, the CD4(+)CD3(-) cells have little CD80 or CD86 expression but do express high levels of the TNF ligands, OX40 ligand and CD30 ligand. We show that Th2-primed cells express the receptors for these TNF ligands and preferentially survive when cocultured with these cells. Furthermore, we show that the preferential survival of OX40(+) T cells and support of memory T cell help for B cells are linked to their association with CD4(+)CD3(-) cells in vivo.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12753741     DOI: 10.1016/s1074-7613(03)00110-9

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  81 in total

Review 1.  New insights into the development of lymphoid tissues.

Authors:  Serge A van de Pavert; Reina E Mebius
Journal:  Nat Rev Immunol       Date:  2010-08-13       Impact factor: 53.106

2.  The chronicity of tonsillitis is significantly correlated with an increase in an LTi cell portion.

Authors:  Jung Hyun Chang; Soochan Kim; Jihye Koo; Peter J L Lane; Sun Och Yoon; Ah Young Park; Kyung-Su Kim; Mi-Yeon Kim
Journal:  Inflammation       Date:  2014-02       Impact factor: 4.092

Review 3.  Approaches to studying costimulation of human antiviral T cell responses: prospects for immunotherapeutic vaccines.

Authors:  Lena Serghides; Mariana Vidric; Tania H Watts
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

4.  Antigen-independent signalosome of CARMA1, PKCθ, and TNF receptor-associated factor 2 (TRAF2) determines NF-κB signaling in T cells.

Authors:  Takanori So; Pejman Soroosh; So-Young Eun; Amnon Altman; Michael Croft
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-31       Impact factor: 11.205

Review 5.  Germinal-center organization and cellular dynamics.

Authors:  Christopher D C Allen; Takaharu Okada; Jason G Cyster
Journal:  Immunity       Date:  2007-08       Impact factor: 31.745

6.  Heterogeneity of lymphoid tissue inducer cell populations present in embryonic and adult mouse lymphoid tissues.

Authors:  Mi-Yeon Kim; Simona Rossi; David Withers; Fiona McConnell; Kai-Michael Toellner; Fabrina Gaspal; Eric Jenkinson; Graham Anderson; Peter J L Lane
Journal:  Immunology       Date:  2008-01-16       Impact factor: 7.397

Review 7.  Induction of intestinal lymphoid tissue formation by intrinsic and extrinsic signals.

Authors:  Daniela Finke
Journal:  Semin Immunopathol       Date:  2009-06-09       Impact factor: 9.623

Review 8.  Development of secondary lymphoid organs.

Authors:  Troy D Randall; Damian M Carragher; Javier Rangel-Moreno
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

9.  Lymphocyte mass cytometry identifies a CD3-CD4+ cell subset with a potential role in psoriasis.

Authors:  Ruru Guo; Ting Zhang; Xinyu Meng; Zhen Lin; Jinran Lin; Yu Gong; Xuesong Liu; Yuetian Yu; Guilin Zhao; Xianting Ding; Xiaoxiang Chen; Liangjing Lu
Journal:  JCI Insight       Date:  2019-03-21

10.  Expression of LLT1 and its receptor CD161 in lung cancer is associated with better clinical outcome.

Authors:  Véronique M Braud; Jérôme Biton; Etienne Becht; Samantha Knockaert; Audrey Mansuet-Lupo; Estelle Cosson; Diane Damotte; Marco Alifano; Pierre Validire; Fabienne Anjuère; Isabelle Cremer; Nicolas Girard; Dominique Gossot; Agathe Seguin-Givelet; Marie-Caroline Dieu-Nosjean; Claire Germain
Journal:  Oncoimmunology       Date:  2018-01-29       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.